PI4K
PI4K (phosphatidylinositol 4-kinase) catalyzes the first committed steps for phosphatidylinositol 4,5-bisphosphate biosynthesis. It is associated with viral replication and cancer.
Products for PI4K
- Cat.No. Product Name Information
-
GC32381
BF738735
BF738735 is a phosphatidylinositol 4-kinase III beta (PI4KIIIβ) inhibitor with an IC50 of 5.7 nM.
-
GC32163
BQR-695 (NVP-BQR695)
NVP-BQR695
BQR-695 (NVP-BQR695) is a PI4KIIIβ inhibitor with IC50s of 80 and 3.5 nM for human PI4KIIIβ and Plasmodium variant of PI4KIIIβ, respectively. -
GC65309
GSK-F1
GSK-F1 (Compound F1) is an orally active PI4KA inhibitor with pIC50 values of 8.0, 5.9, 5.8, 5.9, 5.9 and 6.4 against PI4KA, PI4KB, PI3KA, PI3KB, PI3KG and PI3KD, respectively.
-
GC32118
KDU691
An antimalarial compound
-
GC38033
KDU731
KDU731, an orally active C.
-
GC62109
MMV390048
MMV390048 is a representative of a new chemical class of Plasmodium PI4K inhibitor (Kdapp=0.3 ?M).
-
GC39155
PI-273
PI-273 is a first reversibly and specific phosphatidylinositol 4-kinase (PI4KIIα) inhibitor with an IC50 of 0.47 μM. PI-273 can inhibit breast cancer cell proliferation, block the cell cycle and induce cell apoptosis.
-
GC72785
PI4K-IN-1
PI4K-IN-1 (compound 44) is a potent PI4KIII inhibitor, with pIC50 values of 9.0 and 6.6 for PI4KIIIα and PI4KIIIβ, respectively.
-
GC15508
PI4KIII beta inhibitor 3
PI4KIII beta inhibitor 3
-
GC30777
PI4KIIIbeta-IN-10
PI4KIIIbeta-IN-10 is a potent PI4KIIIβ inhibitor with an IC50 of 3.6 nM.
-
GC32847
PI4KIIIbeta-IN-9
PI4KIIIbeta-IN-9 is a potent PI4KIIIβ inhibitor with an IC50 of 7 nM. PI4KIIIbeta-IN-9 also inhibits PI3Kδ and PI3Kγ with IC50s of 152 nM and 1046 nM, respectively.
-
GC13089
PIK-93
PI3Kγ/PI4KIIIβ/PI3Kα inhibitor
-
GC32199
T-00127_HEV1
T-00127_HEV1 is a phosphatidylinositol 4-kinase III beta (PI4KB) inhibitor with an IC50 of 60 nM.
-
GC18164
UCB9608
PI4KIIIβ inhibitor